51.03 F
New York, US
March 15, 2026
PreetNama
English News

Chinese hypersonic test like a ‘Sputnik moment’: Top US general

The Pentagon’s top general said Wednesday that China’s recent test of an earth-circling hypersonic missile was akin to the Soviet Union’s stunning launch of the world’s first satellite, Sputnik, in 1957, which sparked the superpowers’ space race.

Marks Milley, chairman of the Joint Chiefs of Staff, confirmed for the first time the Chinese test of a nuclear-capable missile that would be very difficult to defend against.

“What we saw was a very significant event of a test of a hypersonic weapon system. And it is very concerning,” Milley told Bloomberg TV.

“I don’t know if it’s quite a Sputnik moment, but I think it’s very close to that,” he said.

“It’s a very significant technological event that occurred… and it has all of our attention.”

The US Department of Defense had previously declined to confirm the test, first reported by the Financial Times on October 16.

The newspaper said the August test launch caught Washington by surprise.

The missile circled the Earth at a low altitude and a velocity of more than five times the speed of sound, although it missed its target by more than 30 kilometers (19 miles), according to the Financial Times.

China denied the report, saying it was a routine test of a reusable space vehicle.

Hypersonics are the new frontier in missile technology, because they fly lower and so are harder to detect than ballistic missiles, can reach targets more quickly, and are maneuverable.

That makes them more dangerous, particularly if mounted with nuclear warheads.

The United States, Russia, China and North Korea have all tested hypersonics and several others are developing the technology.

China in 2019 unveiled a hypersonic medium-range missile, the DF-17, which can travel around 2,000 kilometres and can carry nuclear warhead

The missile mentioned in the FT story is a different one, with a longer range. It can be launched into orbit before coming back into the atmosphere to hit its target.

Asked Wednesday about China’s test, Pentagon spokesman John Kirby again declined to confirm it.

But he said that any major advancement in China’s military capabilities does “very little to help decrease tensions in the region and beyond.”

Such advances, he said, are “paired with a foreign and defense policy approach that uses intimidation and coercion of neighboring nations to yield to China’s interests.”

Related posts

Black Lives Matter: UK parliament to review iconic colonial India painting

On Punjab

Joe Biden pressed on emissions goal as climate summit nears

On Punjab

he plans for AstraZeneca’s new headquarters and large R&D campus in Cambridge were unveiled in 2013, but its costs and timeframe have exceeded the initial estimate of 330 million pounds and an aimed completion date of 2016. AstraZeneca, which has a large portfolio of treatments for diseases such as cancer, heart disease and diabetes, said the centre would support research into specialised medicines and next-generation therapeutics, including gene-editing and cell therapies. “We will have advances that could come to the clinic in the next three, four years, that can lead to really effective new drugs in various aspects of treating cancer,” Dr Susan Galbraith, AstraZeneca’s executive vice president, Oncology Research & Development, told Reuters in an interview. “I’m very optimistic about the fact that we can make a big difference to this disease in the coming decade”.

On Punjab